Brainstorm Cell Therapeutics Inc. BCLI
Set alert
0.86 USD -0.05 -5.35%
As of Oct 30, 3:46 PM ET
0.856 Day range 0.943
0.48 52-week range 1.44
- YTD
- +56.38%
- 1 year
- +32.32%
- Open
- 0.8703
- Prev close
- 0.90875
- Mkt cap
- 9.49M
- Vol
- 3.48K
- Avg vol
- 23.42K
- EPS
- -0.93
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.856
- High
- 0.943
- Forward P/E
- -0.91
- Beta
- 0.39
- Short ratio
- 1.25
- Inst. own
- 13.90%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.70
- 200-d avg
- 4.88
- 1y target
- 23.45
YTD chart
Signals (54)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 29, 2026 | 2 days ago |
| MACD: Buy Signal | Oct 29, 2026 | 2 days ago |
| SMA: Bearish | Oct 15, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 8, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 7, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 5, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 2, 2026 | 4 weeks ago |
| SMA: Bullish | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 16, 2026 | 1 month ago |
| SMA: Bullish | Sep 10, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 4, 2026 | 1 month ago |
| RSI: Overbought | Aug 18, 2026 | 2 months ago |
| SMA: Bullish | Aug 14, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 14, 2026 | 2 months ago |
| SMA: Bearish | Jul 31, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 13, 2026 | 3 months ago |
| RSI: Overbought | Jul 1, 2026 | 4 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| SMA: Bearish | Jun 12, 2026 | 4 months ago |
| SMA: Bullish | Jun 10, 2026 | 4 months ago |
| SMA: Bearish | Jun 9, 2026 | 4 months ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| SMA: Bearish | Jun 5, 2026 | 4 months ago |
| SMA: Bullish | Jun 4, 2026 | 4 months ago |
| SMA: Bearish | Jun 3, 2026 | 5 months ago |
| SMA: Bullish | Jun 2, 2026 | 5 months ago |
| SMA: Bullish | May 27, 2026 | 5 months ago |
| SMA: Bearish | May 22, 2026 | 5 months ago |
| MACD: Buy Signal | May 14, 2026 | 5 months ago |
| SMA: Bullish | May 12, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bullish | May 7, 2026 | 5 months ago |
| SMA: Bearish | May 6, 2026 | 5 months ago |
| SMA: Bullish | May 5, 2026 | 5 months ago |
| SMA: Bearish | Apr 28, 2026 | 6 months ago |
| SMA: Bearish | Apr 24, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 2, 2026 | 7 months ago |
| RSI: Overbought | Mar 16, 2026 | 7 months ago |
| SMA: Bullish | Mar 12, 2026 | 7 months ago |
| MACD: Buy Signal | Feb 23, 2026 | 8 months ago |
| SMA: Bullish | Feb 20, 2026 | 8 months ago |
| SMA: Bearish | Feb 12, 2026 | 8 months ago |
| SMA: Bullish | Feb 11, 2026 | 8 months ago |
| SMA: Bearish | Feb 4, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 4, 2026 | 8 months ago |
| SMA: Bullish | Feb 3, 2026 | 9 months ago |
| SMA: Bearish | Feb 2, 2026 | 9 months ago |
| SMA: Bullish | Jan 28, 2026 | 9 months ago |
| SMA: Bearish | Jan 27, 2026 | 9 months ago |
| SMA: Bullish | Jan 23, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 13, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 8, 2026 | 9 months ago |
Financial health
Altman Z-Score
-820.33 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -0.5×
FY 2016 5y median -0.9× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B -0.5×
FY 2016 5y median -1.6× FY 2025
P/FCF -0.7×
FY 2016 5y median -1.3× FY 2025
EV/EBITDA -0.5×
FY 2016 5y median -1.1× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -136.8%
FY 2016 5y median -75.4% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE 100.1%
FY 2016 5y median 100.1% FY 2025
ROIC 98.7%
FY 2016 5y median 98.7% FY 2025
ROA -1441.5%
FY 2016 5y median -287.3% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income 14.9%
FY 2016 FY 2025
EPS (diluted) -150.7%
FY 2016 FY 2025
Free Cash Flow 23.3%
FY 2016 FY 2025
Financial Health
Current Ratio 0.0×
FY 2016 5y median 0.2× FY 2025
Quick Ratio 0.0×
FY 2016 5y median 0.2× FY 2025
Debt / Equity -0.0×
FY 2016 5y median -0.1× FY 2025
Net Debt / EBITDA -0.0×
FY 2016 5y median -0.0× FY 2025
Interest Coverage 0.0×
FY 2016 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31